熱門資訊> 正文

Theriva Biologics GAAP每股收益为-2.08美元

2026-03-13 03:12

Theriva Biologics, Inc.(TOVX) 0

Theriva Biologics press release (TOVX): FY GAAP EPS of -$2.08.
Cash and cash equivalents totaled $13.1 million as of December 31, 2025, compared to $11.6 million as of December 31, 2024. The Company’s current cash of approximately $15.2 million at February 26, 2026

More on Theriva Biologics

Seeking Alpha’s Quant Rating on Theriva Biologics
Historical earnings data for Theriva Biologics
Financial information for Theriva Biologics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。